OS-078-YI Hepatic Decompensation As an Aetiology-Dependent Determinant of Mortality in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab Ciro Celsa , Giuseppe Cabibbo , Claudia Fulgenzi , Bernhard Scheiner , Salvatore Battaglia , Antonio D'Alessio , Giulia Manfredi , Bernardo Stefanini , Naoshi Nishida , Peter R. Galle , Kornelius Schulze , Henning Wege , Roberta Ciccia , Wei-Fan Hsu , Caterina Vivaldi , Brooke Wietharn , Po-Ting Lin , Angelo Pirozzi , Tiziana Pressiani , Andrea Dalbeni , Leonardo Antonio Natola , Alessandra Auriemma , Cristina Rigamonti , Michela Emma Burlone , Alessandro Parisi , Yi-Hsiang Huang , Pei-Chang Lee , Celina Ang , Thomas Marron , Matthias Pinter , Jaekyung Cheon , Hong Jae Chon , Samuel Phen , Amit Singal , Anuhya Gampa , Anjana Pillai , Robert Thimme , Arndt Vogel , Noha Soror , Susanna V. Ulahannan , Rohini Sharma , David Sacerdoti , Mario Pirisi , Lorenza Rimassa , Chun-yen Lin , Anwaar Saeed , Natascha Roehlen , Gianluca Masi , Martin Schoenlein , Johann Von Felden , Masatoshi Kudo , Alessio Cortellini , Calogero Camma , David J. Pinato Journal of Hepatology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
